Blog | HemaCare

HemaCare Apheresis Materials Aid COVID-19 Vaccine Clinical Trial

Oct 12, 2021 10:30:00 AM / by Nancy Andon, MSc posted in Apheresis, T Cells

0 Comments

Researchers involved in the clinical investigation of a new COVID-19 vaccine cited using HemaCare healthy donor starting materials for their study.

The scientists, most of whom work at ImmunityBio in Culver City, CA, are conducting a Phase 1 clinical trial for their new dual-antigen COVID-19 vaccine. [1]

Read More

What Impacts Starting Material Quality? Part 2: Apheresis Best Practices

Nov 5, 2019 10:11:00 AM / by Nancy Andon, MSc posted in Apheresis

0 Comments

Welcome to the 2nd segment of our blog series on what impacts cell therapy starting material quality. This week, we examine what comprises apheresis best practices, which are critical to the quality of apheresis materials.

Read More

What Impacts Starting Material Quality? Part 1: Donor Variability

Oct 29, 2019 10:00:00 AM / by Nancy Andon, MSc posted in Apheresis, Cell Therapy

0 Comments

This week we begin a 3-part blog series on the intricacies of optimizing the quality of cell therapy starting materials. Cell and gene therapies have the potential to transform healthcare. Successfully bringing these therapies to the market, however, is a challenge. The intrinsic variability of living cells carries an increased risk and cost to therapeutic development not encountered with traditional medicine. Those risks are being countered with innovative strategies and technologies that experts hope will bridge the translational gap between research and industry.

Read More

Mobilization Mechanics: The Complex World of Stem Cell Mobilization

Jul 24, 2019 10:11:00 AM / by Nancy Andon, MSc posted in Apheresis, Stem Cells

0 Comments

Stem cells are the foundation from which all other cells with specialized functions are generated. Stem cells are primarily found in the bone marrow, where they are produced, but can be induced to migrate into the peripheral blood circulation through a process known as mobilization.

Read More

New HemaCare Publication Stipulates the Need for Healthy Donor Tissue

Jul 2, 2019 8:50:00 AM / by Nancy Andon, MSc posted in Apheresis, Cell Therapy

0 Comments

HemaCare has just announced the publication of their latest article in the popular stem cell industry periodical BioInformant. [1] The article focuses on the need for healthy donor starting material to keep up with growing demands in the cell and gene therapy industry.

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts